SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-16-766988
Filing Date
2016-11-14
Accepted
2016-11-14 07:56:02
Documents
1
Effectiveness Date
2016-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 15 d273933d1512b.htm 15-12B 10366
  Complete submission text file 0001193125-16-766988.txt   11601
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-35953 | Film No.: 161990636
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences